Investigating the role of human papillomavirus in squamous cell carcinoma of the temporal bone

Head and Neck Oncology

Volumn 5, Issue 2, 2013, Pages

  Masterson, L ^a   Winder, D M ^a   Marker, A ^a   Sterling, J C ^a   Sudhoff, H ^b   Moffat, D ^a   Goon, P K C ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b Bielefield Academic Teaching Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN BETA CHAIN; PROTEIN P16; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURATION; DISEASE FREE SURVIVAL; DNA PURIFICATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTION RISK; MALE; MALIGNANT TRANSFORMATION; MORBIDITY; MORTALITY; MUTATIONAL ANALYSIS; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; TEMPORAL BONE TUMOR; VIRUS DETECTION; WART VIRUS;

EID: 84874593448     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gidley PW, Roberts DB, Sturgis EM. Squamous cell carcinoma of the temporal bone. Laryngoscope. 2010; 120: 1144-51.
2. Moffat DA, Wagstaff SA, Hardy DG. The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone. Laryngoscope. 2005; 115: 341-7.
3. Sasaki C T. Distant metastases from ear and temporal bone cancer. ORL J Otorhinolaryngol Relat Spec. 2001; 63: 250-251.
4. Lim LH, Goh YH, Chan YM, Chong VF, Low WK. Malignancy of the temporal bone and external auditory canal. Otolaryngol Head Neck Surg. 2000; 122(6): 882-6.
5. Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S. The prevalence of human papillomavirus in oropharyngeal and non-oropharyngeal head and neck cancer: a systematic review and meta-analysis of trends by time and region. Head Neck. 2012; doi: 10.1002/hed.22015.
6. A. Psyrri and E. Cohen. Oropharyngeal cancer: clinical implications of the HPV connection. Ann Oncol. 2011; 22(5): 997-9.
7. de Martel C, Ferlay F, Franceschi S, Vignat J, Bray F, Forman D et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 2012; 13(6): 607-15.
8. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999; 189(1): 12-9.
9. Harro CD, Pang YY, Roden RB, Hildesheim A, Wang Z, Reynolds MJ, Mast TC, Robinson R, Murphy BR, Karron RA, Dillner J, Schiller JT, Lowy DR. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst. 2001; 93(4): 284-92.
10. Jin YT, Tsai ST, Li C, Chang KC, Yan JJ, Chao WY et al. Prevalence of human papillomavirus in middle ear carcinoma associated with chronic otitis media. Am J Pathol. 1997; 150: 1327-33.
11. Wang S, Yee H, Wen HY, Wang BY. Papillomas of the external ear canal: report of ten cases in Chinese patients with HPV in situ hybridisation. Head Neck Pathol. 2009; 3: 207-11.
12. Miah MS, Mairi C, White SJ, Hussain SSM. Malignant transformation from benign papillomatosis of the external auditory canal. Otol Neurotol. 2012; 33: 643-7.
13. Marioni G, Altavilla G, Busatto G, Blandamura S, De Filippis C, Staffieri A. Detection of human papillomavirus in temporal bone inverted papilloma by polymerase chain reaction. Act Otolaryngol. 2003; 123: 367-71.
14. Callis G, Sterchi D. Decalcification of Bone: Literature Review and Practical Study of Various Decalcifying Agents, Methods, and Their Effects on Bone Histology. The Journal of Histotechnology 1998; 21: 49-58.
15. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlee F, Hild- esheim A et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000; 38: 357-361.
16. Winder DM, Ball SL, Vaughan K, Hanna N, Woo YL, Fränzer JT et al. Sensitive HPV detection in oropharyngeal cancers. BMC Cancer 2009; 9: 440.
17. Markoulatos P, Georgopoulou A, Siafakas N, Plakokefalos E, Tzanakaki G, Kourea-Kremastinou J. Laboratory diagnosis of common herpesvirus infections of the central nervous system by a multiplex PCR assay. J Clin Microbiol. 2001; 39: 4426-32.
18. Huang CC, Qiu JT, Kashima ML, Kurman RJ, Wu TC. Generation of type-specific probes for the detection of single-copy human papillomavirus papillomavirus by a novel in situ hybridization method. Mod Pathol. 1998; 11: 971-7.
19. Mehanna H, Olaleye O, Licitra L. Oropharyngeal cancer - is it time to change management according to human papilloma virus status? Curr Opin Otolaryngol Head Neck Surg. 2012; 20: 120-4.
20. Kusser WC, Levin DB, Glickman BW. Sensitive two-stage PCR of p53 genomic DNA exons 5-9. PCR Methods Appl. 1993; 2: 250-2.
21. Oliver M, Eeles R, Holstein M, Khan MA, Harris CC, Hainaut P. The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat. 2002; 19: 607-614.
22. Ang KK. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
23. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004; 4: 757-68.
24. Major T, Szarka K, Sziklai I, Gergely L, Czeglédy J. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas. J Clin Pathol. 2005; 58: 51-5.
25. Cason J, Mant CA. High-risk mucosal human papillomavirus infections during infancy and childhood. J Clin Virol. 2005; 32 Suppl 1: S52-8.
26. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA. 2012; 307: 693-703.
27. Gottschling M, Göker M, Köhler A, Lehmann MD, Stockfleth E, Nindl I. Cutaneotropic human beta-/gamma-papillomaviruses are rarely shared between family members. J Invest Dermatol. 2009; 129: 2427-34.
28. Bosch FX, Qiao YL, Castellsague X. The epidemiology of human papillomavirus infection and its association with cervical cancer. International Journal of Gynecology and Obstetrics. 2006; 94 Suppl 1: S8-S21.
29. Syrjänen S, Puranen M. Human papillomavirus infections in children: the potential role of maternal transmission. Crit Rev Oral Biol Med. 2000; 11: 259-74.
30. Fakhry C, Sugar E, D'Souza G, Gillison M. Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One 2010; 5(7): e11918.